Abstract
Recent kidney regeneration research using induced pluripotent stem cells (iPSCs) has made significant progress. By mimicking the developmental processes of the kidney, human iPSCs can be differentiated stepwise into two major embryonic kidney progenitors, nephron progenitor cells (NPCs) and ureteric bud (UB) cells, which can form nephron and UB organoids, respectively. Furthermore, by combining the two progenitors, kidney organoids can be generated, in which glomeruli, renal tubules, and collecting ducts are interconnected. Cell therapies using human iPSC-derived NPCs ameliorate acute kidney injury (AKI) in mice. Using human iPSC-derived kidney lineage cells and organoids, models for inherited kidney disorders have been generated for the pathological analysis and drug discovery. This chapter summarizes the current status and future perspectives of research on the directed differentiation of iPSCs into kidney lineages and its applications, such as cell therapies, kidney reconstruction, and disease modeling.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
